Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q2 2022 · 10-Q
Revenue$7.63M$7.63M+5.9% vs Q2 2021 Net Income$634.72K$634.72K−45.8% vs Q2 2021 EPS Diluted$0.07$0.07−50.0% vs Q2 2021 Operating Income$1,194,374−40.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,640,240+7.4% Margins · derivedOperating margin15.6%−12.0 pt vs Q2 2021
Net margin8.3%−7.9 pt vs Q2 2021
ended May 31, 2022 · filed Jul 11, 2022 · 41 d after period end